[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354950-105":59,"doc-detail-354950-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","gsta1-deficiency-drives-neuroendocrine-differentiation-via-tnfrsf13bc-foschga-axis-in-prostate-cancer","GSTA1 deficiency drives neuroendocrine differentiation via TNFRSF13B/c-FOS/CHGA axis in prostate cancer","","Androgen deprivation therapy (ADT) is central to prostate cancer treatment, yet prolonged use increases neuroendocrine differentiation and contributes to hormone-refractory subtypes. This study investigates molecular mechanisms by applying digital spatial profiling (DSP) sequencing to prostate cancer tissue microarrays from five patients receiving neoadjuvant therapy. Results identify GSTA1 as a driver: ENZ suppresses GSTA1, and knockdown elevates reactive oxygen species that activate TNFRSF13B, inducing c-FOS/c-JUN transcriptional regulation of CHGA and promoting the neuroendocrine phenotype.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/gsta1-deficiency-drives-neuroendocrine-differentiation-via-tnfrsf13bc-foschga-axis-in-prostate-cancer/354950/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/gsta1-deficiency-drives-neuroendocrine-differentiation-via-tnfrsf13bc-foschga-axis-in-prostate-cancer/354950.png","ImageObject",300,407,{"name":92,"@type":93},"Lucas Martin","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What clinical context motivates this study?","Question",{"text":112,"@type":113},"Androgen deprivation therapy is a cornerstone of prostate cancer care, but prolonged ADT increases the risk of neuroendocrine differentiation, contributing to hormone-refractory subtypes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did the researchers study neuroendocrine differentiation mechanisms?",{"text":117,"@type":113},"They used digital spatial profiling (DSP) sequencing on tissue microarrays from five prostate cancer patients who received neoadjuvant therapy before radical prostatectomy.",{"name":119,"@type":110,"acceptedAnswer":120},"What mechanism links GSTA1 deficiency to neuroendocrine differentiation?",{"text":121,"@type":113},"GSTA1 knockdown raises intracellular reactive oxygen species (ROS), which activates TNFRSF13B; TNFRSF13B then induces c-Fos, forming a complex with c-Jun to transcriptionally regulate CHGA and promote a neuroendocrine phenotype.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},354950,1790168128,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},8796095360427,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Ivyspring  \nInternational Publisher  \nInternationalJournal of Biological Sciences  \n2026; 22(3): 1632-1647. doi: 10.7150/ijbs.120497  \nResearch Paper  \nGSTA1 deficiency drives neuroendocrine differentiation via TNFRSF13B/c-FOS/CHGA axis in prostate cancer  \nJiajun Qian1, 2*, Yang Luo1, 2*, Yao Fu3, Wenli Diao1, 2, Qiubo Ding1, 2, Wei Chen1, 2􀀍, Xuefeng Qiu1, 2􀀍, Hongqian Guo1, 2􀀍  \n1. Department of Urology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing 210008, China.  \n2. Institute of Urology, Nanjing University, Nanjing 210008, China.  \n3. Department of Pathology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing 210008, China.  \n*Equal contribution.  \n􀀍 Corresponding authors: Wei Chen, Department of Urology, Drum Tower Hospital, Medical School of Nanjing University, Nanjing 210008, China. Tel: 86-25-83105665, Fax: 86-25-83317016. E-mail: [chenw@njglyy.com. Xuefeng Qiu](chenw@njglyy.com. Xuefeng Qiu), Department of Urology, Drum Tower Hospital, Medical School of Nanjing University, Nanjing 210008, China. Tel: 86-25-83105665, Fax: [86-25-83317016. E-mail: Xuefeng_qiu@nju.edu.cn. Hongqian Guo](86-25-83317016. E-mail: Xuefeng_qiu@nju.edu.cn. Hongqian Guo), Department of Urology, Drum Tower Hospital, Medical School of Nanjing University, Nanjing 210008, China. Tel: 86-25-83105665, Fax: [86-25-83317016. E-mail: dr.ghq@nju.edu.cn](86-25-83317016. E-mail: dr.ghq@nju.edu.cn).© The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License ([https://creativecommons.org/licenses/by/4.0/](https://creativecommons.org/licenses/by/4.0/)). See [https://ivyspring.com/terms](https://ivyspring.com/terms) for full terms and conditions.  \nReceived: 2025.06.28; Accepted: 2026.01.06; Published: 2026.01.14  \nAbstract  \nRationale: Androgen deprivation therapy (ADT) is the cornerstone of prostate cancer (PCa) treatment. Prolonged ADT inevitably increases the risk of neuroendocrine differentiation, which leads to the development of hormone-refractory subtypes. In this study, we explored the molecular mechanisms underlying theneuroendocrine differentiation of PCa cells under ADT.  \nMethods: We performed digital spatial profiling (DSP) sequencing using tissue microarrays from five patients with PCa who underwent neoadjuvant therapy before radical prostatectomy at the Nanjing Drum Tower Hospital.  \nResults: Glutathione S-transferase alpha 1 (GSTA1) was identified as a driver of neuroendocrine differentiation in PCa cells using DSP sequencing of tissue microarrays prepared from clinical samples. Following enzalutamide (ENZ) treatment, GSTA1 expression is inhibited. Decreased GSTA1 levels have also been reported in patients with neuroendocrine PCa (NEPC) . GSTA1 knockdown leads to increased intracellular reactive oxygen species (ROS), which can activate the inflammatory gene, tumor necrosis factor receptor superfamily member 13B (TNFRSF13B) . TNFRSF13B induces c-Fos expression, forming a transcriptional complex with c-Jun, thereby regulating chromogranin A (CHGA) and promoting theneuroendocrine phenotype.  \nConclusion: Our study suggested that GSTA1 deficiency leads to elevated ROS levels and activation of TNFRSF13B and c-FOS, which subsequently transcriptionally regulate CHGA and ultimately driveneuroendocrine differentiation in PCa.  \nKeywords: prostate cancer; neuroendocrine differentiation; glutathione S-transferase alpha 1; androgen deprivation therapy  \nIntroduction  \nNeuroendocrine prostate cancer (NEPC) is a late manifestation of prostate cancer (PCa), regarded as a hormone-refractory subtype [1, 2] . NEPC is gradually being considered as a subset of castration-resistant prostate cancer (CRPC), overcoming dependence on the AR pathway and acquiring the histological characteristics of neuroendocrine differentiation [3, 4] . Although the application of next-generation androgen receptor inhibitors such as abiraterone and  \nenzalutamide (EN","cbCailV0tKVN9pY7","https://ap.wps.com/l/cbCailV0tKVN9pY7","pdf",8093785,16,"English","# Abstract\n# Introduction\n## Neuroendocrine prostate cancer background\n## Role of inflammation and molecular characteristics\n## c-FOS and AP-1 signaling in transcription","[{\"question\":\"What clinical context motivates this study?\",\"answer\":\"Androgen deprivation therapy is a cornerstone of prostate cancer care, but prolonged ADT increases the risk of neuroendocrine differentiation, contributing to hormone-refractory subtypes.\"},{\"question\":\"How did the researchers study neuroendocrine differentiation mechanisms?\",\"answer\":\"They used digital spatial profiling (DSP) sequencing on tissue microarrays from five prostate cancer patients who received neoadjuvant therapy before radical prostatectomy.\"},{\"question\":\"What mechanism links GSTA1 deficiency to neuroendocrine differentiation?\",\"answer\":\"GSTA1 knockdown raises intracellular reactive oxygen species (ROS), which activates TNFRSF13B; TNFRSF13B then induces c-Fos, forming a complex with c-Jun to transcriptionally regulate CHGA and promote a neuroendocrine phenotype.\"}]","GSTA1 deficiency drives neuroendocrine differentiation via TNFRSF13B/c-FOS/CHGA axis in prostate cancer | PDF",1790115009,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/69c187b27e15696c66939d1e827ab60a.webp",983,1272,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/afb0cb5ef45015781459c5ab73cced5a.webp",982,1270,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/80d04f8a8e02a888bde74ee17fc3f337.webp",981,1269,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c98c2c51cad9d70b644384c39e75fa4d.webp",980,1268]